Cargando…
Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
A live-attenuated, human vaccine against mosquito-borne yellow fever virus has been available since the 1930s. The vaccine provides long-lasting immunity and consistent mass vaccination campaigns counter viral spread. However, traditional egg-based vaccine manufacturing requires about 12 months and...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153634/ https://www.ncbi.nlm.nih.gov/pubmed/30091043 http://dx.doi.org/10.1007/s00253-018-9275-z |